Literature DB >> 10981193

Screening for osteoporosis in community-dwelling adults with mental retardation.

C V Tyler1, C W Snyder, S Zyzanski.   

Abstract

Osteoporosis screening of adults ages 40 to 60 who attended community-based adult training centers was conducted utilizing dual-energy X-ray absorptiometry (DEXA) measurements of the calcaneus. Valid measurements were obtained on 107 individuals, a response rate of 94%. One fifth of the sample (21%) had osteoporosis and 34% had osteopenia. On multiple regression analysis, the most significant predictors of BMD were Down syndrome, mobility status, and race. Future studies involving larger samples of middle-age adults with mental retardation/developmental disabilities will clarify the need and optimum age for osteoporosis screening.

Entities:  

Mesh:

Year:  2000        PMID: 10981193     DOI: 10.1352/0047-6765(2000)038<0316:SFOICA>2.0.CO;2

Source DB:  PubMed          Journal:  Ment Retard        ISSN: 0047-6765


  9 in total

Review 1.  Screening tests for adults with intellectual disabilities.

Authors:  Joanne E Wilkinson; Larry Culpepper; Mary Cerreto
Journal:  J Am Board Fam Med       Date:  2007 Jul-Aug       Impact factor: 2.657

2.  Consensus guidelines for primary health care of adults with developmental disabilities.

Authors:  William F Sullivan; John Heng; Donna Cameron; Yona Lunsky; Tom Cheetham; Brian Hennen; Elspeth A Bradley; Joseph M Berg; Marika Korossy; Cynthia Forster-Gibson; Maria Gitta; Chrissoula Stavrakaki; Bruce McCreary; Irene Swift
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

3.  Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities.

Authors:  Kathleen C Watson; Martha J Lentz; Kevin C Cain
Journal:  Womens Health Issues       Date:  2006 Nov-Dec

4.  Bone density and fragility fractures in patients with developmental disabilities.

Authors:  W D Leslie; P S Pahlavan; E B Roe; K Dittberner
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

Review 5.  Endocrine and musculoskeletal abnormalities in patients with Down syndrome.

Authors:  Yousra Hawli; Mona Nasrallah; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

Review 6.  Primary care for women with intellectual disabilities.

Authors:  Joanne E Wilkinson; Mary C Cerreto
Journal:  J Am Board Fam Med       Date:  2008 May-Jun       Impact factor: 2.657

7.  Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis.

Authors:  Kathryn M Ryder; S Bobo Tanner; Laura Carbone; John E Williams; Henry M Taylor; Andrew Bush; Victorina Pintea; Mitchell A Watsky
Journal:  J Bone Miner Metab       Date:  2009-10-06       Impact factor: 2.626

8.  Aging and bone health in individuals with developmental disabilities.

Authors:  Joan Jasien; Caitlin M Daimon; Stuart Maudsley; Bruce K Shapiro; Bronwen Martin
Journal:  Int J Endocrinol       Date:  2012-07-22       Impact factor: 3.257

9.  Osteoporosis associated with antipsychotic treatment in schizophrenia.

Authors:  Haishan Wu; Lu Deng; Lipin Zhao; Jingping Zhao; Lehua Li; Jindong Chen
Journal:  Int J Endocrinol       Date:  2013-04-17       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.